In a small study in biopsy-proven patients with MCGN (n = 17) or FSGS (n = 22), a significant increase in urinary CD80 excretion was found in patients with MCGN in relapse compared to those in remission or to those with FSGS [23]. The gene discussed is CD80; the disease is focal segmental glomerulosclerosis.